ATE194831T1 - Indanylpiperidine als melatonerge wirkstoffe - Google Patents
Indanylpiperidine als melatonerge wirkstoffeInfo
- Publication number
- ATE194831T1 ATE194831T1 AT96401087T AT96401087T ATE194831T1 AT E194831 T1 ATE194831 T1 AT E194831T1 AT 96401087 T AT96401087 T AT 96401087T AT 96401087 T AT96401087 T AT 96401087T AT E194831 T1 ATE194831 T1 AT E194831T1
- Authority
- AT
- Austria
- Prior art keywords
- branched
- straight
- melatonergic
- hydrogen
- indanylpiperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45892195A | 1995-06-02 | 1995-06-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE194831T1 true ATE194831T1 (de) | 2000-08-15 |
Family
ID=23822638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96401087T ATE194831T1 (de) | 1995-06-02 | 1996-05-17 | Indanylpiperidine als melatonerge wirkstoffe |
Country Status (11)
Country | Link |
---|---|
US (1) | US5703239A (de) |
EP (1) | EP0745591B1 (de) |
JP (1) | JPH08333338A (de) |
AT (1) | ATE194831T1 (de) |
AU (1) | AU705431B2 (de) |
CA (1) | CA2176766A1 (de) |
DE (1) | DE69609379T2 (de) |
DK (1) | DK0745591T3 (de) |
ES (1) | ES2150645T3 (de) |
GR (1) | GR3034645T3 (de) |
PT (1) | PT745591E (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2753706B1 (fr) * | 1996-09-20 | 1998-10-30 | Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
CA2540197A1 (en) * | 2003-09-26 | 2005-04-07 | Pfizer Products Inc. | Treatment of neurological disorders related to rapid eye movement (rem) sleep disturbances with npy y5 receptor antagonists |
MXPA06003380A (es) * | 2003-09-26 | 2006-06-08 | Pfizer Prod Inc | Uso de antagonista del receptor npy y5 para el tratamiento de trastornos del ritmo circadiano. |
TW200621677A (en) * | 2004-09-21 | 2006-07-01 | Astellas Pharma Inc | Cyclic amine derivative or salt thereof |
US20060122227A1 (en) * | 2004-09-29 | 2006-06-08 | Lior Zelikovitch | Process for alkylating secondary amines and the use in donepezil preparation thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63239220A (ja) * | 1987-03-27 | 1988-10-05 | Taiyo Yakuhin Kogyo Kk | 脳循環代謝改善剤 |
FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
FR2635105B1 (fr) * | 1988-08-03 | 1991-01-25 | Synthelabo | Derives de piperazine et leur procede de preparation |
US5541228A (en) * | 1994-10-14 | 1996-07-30 | Bristol-Myers Squibb Co. | Melatonergic agents |
-
1996
- 1996-04-16 US US08/633,362 patent/US5703239A/en not_active Expired - Fee Related
- 1996-05-16 CA CA002176766A patent/CA2176766A1/en not_active Abandoned
- 1996-05-17 PT PT96401087T patent/PT745591E/pt unknown
- 1996-05-17 EP EP96401087A patent/EP0745591B1/de not_active Expired - Lifetime
- 1996-05-17 DK DK96401087T patent/DK0745591T3/da active
- 1996-05-17 ES ES96401087T patent/ES2150645T3/es not_active Expired - Lifetime
- 1996-05-17 AT AT96401087T patent/ATE194831T1/de not_active IP Right Cessation
- 1996-05-17 DE DE69609379T patent/DE69609379T2/de not_active Expired - Fee Related
- 1996-05-31 AU AU54682/96A patent/AU705431B2/en not_active Ceased
- 1996-06-03 JP JP8139972A patent/JPH08333338A/ja active Pending
-
2000
- 2000-10-19 GR GR20000402331T patent/GR3034645T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0745591A1 (de) | 1996-12-04 |
ES2150645T3 (es) | 2000-12-01 |
DK0745591T3 (da) | 2000-11-20 |
JPH08333338A (ja) | 1996-12-17 |
CA2176766A1 (en) | 1996-12-03 |
AU705431B2 (en) | 1999-05-20 |
AU5468296A (en) | 1996-12-12 |
DE69609379T2 (de) | 2001-03-08 |
US5703239A (en) | 1997-12-30 |
DE69609379D1 (de) | 2000-08-24 |
GR3034645T3 (en) | 2001-01-31 |
EP0745591B1 (de) | 2000-07-19 |
PT745591E (pt) | 2001-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60037892D1 (de) | Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis | |
DE60015927D1 (en) | Phenylharnstoff und phenylthioharnstoffderivate | |
IL178350A0 (en) | Vitamin d derivatives | |
MXPA02001314A (es) | Derivado de carbamato y fungicida agricola/horticola. | |
NO942610D0 (no) | Heterosykliske forbindelser og deres fremstilling og anvendelse | |
ES2173081T3 (es) | Derivados de benzo- y pirido-pirano que tienen actividad ansilitica y anti-consulsionante. | |
ATE194831T1 (de) | Indanylpiperidine als melatonerge wirkstoffe | |
DE69612540D1 (de) | Verwendung von Hydantoin-Derivaten zur Herstellung eines Medikaments zur Behandlung von Krankheiten in Zusammenhang mit aktivem Sauestoff und freien Radikalen | |
FI914007A (fi) | 4-substituerade dihydropyrido (4,3-d) pyrimidiner som smaertslindrande och lokala inflammationshaemmande medel vid vaord av hudsjukdomar. | |
ATE496020T1 (de) | Carbazuckeraminderivate und mittel gegen störungen des glycolipidmetabolismus, die diese als wirkstoff enthalten | |
FI933492A0 (fi) | Lipoxigenas inhiberande hydroxaminsyra- och n-hydroxiureaderivat | |
ATE245643T1 (de) | Substituierte isoxazolylthiophenverbindungen | |
AP2000002001A0 (en) | Hydroxamic acid derivatives as inhibitors of the production of human CD23 and of the tnf relaease. | |
DE69911373D1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
TR200102205T2 (tr) | Anti-konvülsan türevlerinin bulimia nevruza tedavisinde kullanılmaları. | |
DE69527854D1 (de) | Derivate substituierter amidinonaphthylester | |
ATE220665T1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |